Evidence map›Paper›PMID 26880456›Full record

ArticleKidney international2016

Uroplakin 1b is critical in urinary tract development and urothelial differentiation and homeostasis.

Ashley R Carpenter, M Brian Becknell, Christina B Ching, Edward J Cuaresma, Xi Chen, David S Hains, Kirk M McHugh

Abstract read
In one paragraph

Article in Kidney international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Spatiotemporal landscape of kidney in a mouse model of hyperuricemia at single-cell level.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  9. Article
  10. Virulence Factors inIndian journal of microbiology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ashley R CarpenterMolecular and Human Genetics, Nationwide Children's Hospital, Columbus, Ohio, USA; College of Medicine, Ohio State University, Columbus, Ohio, USA. Electronic address: ashley.carpenter@nationwidechildrens.org.
M Brian BecknellCollege of Medicine, Ohio State University, Columbus, Ohio, USA.
Christina B ChingCollege of Medicine, Ohio State University, Columbus, Ohio, USA.
Edward J CuaresmaUrology, Nationwide Children's Hospital, Columbus, Ohio, USA.
Xi ChenMolecular and Human Genetics, Nationwide Children's Hospital, Columbus, Ohio, USA.
David S HainsChildren's Foundation Research Institute at Le Bonheur Children's Hospital, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Kirk M McHughMolecular and Human Genetics, Nationwide Children's Hospital, Columbus, Ohio, USA; Division of Anatomy, Ohio State University, Columbus, Ohio, USA.
Nationwide Children's Hospital · USThe Ohio State University · USUniversity of Tennessee Health Science Center · US

Funding

Model of Congenital Obstructive Nephropathy-Biomarker & Therapeutic DevelopmentR01DK085242 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BATES, CARLTON MATTHEW, MCHUGH, KIRK M. · 2010 to 2014
$1.6M
A Genetic Model of Urogenital Development &ObstructionR01DK070907 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI MCHUGH, KIRK M. · 2005 to 2008
$1.2M
Role of urothelium in epithelial integrity and innate defense of the kidneyK08DK102594 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BECKNELL, BRIAN · 2015 to 2019
$745k
NIDDK NIH HHS K08 DK102594NIDDK NIH HHS R01 DK070907NIDDK NIH HHS R01 DK085242NIDDK NIH HHS R01-DK085242NIDDK NIH HHS R01-DK70907
6 · The paper itself

Abstract

Proper development and maintenance of urothelium is critical to its function. Uroplakins are expressed in developing and mature urothelium where they establish plaques associated with the permeability barrier. Their precise functional role in development and disease is unknown. Here, we disrupted Upk1b in vivo where its loss resulted in urothelial plaque disruption in the bladder and kidney. Upk1b(RFP/RFP) bladder urothelium appeared dysplastic with expansion of the progenitor cell markers, Krt14 and Krt5, increased Shh expression, and loss of terminal differentiation markers Krt20 and uroplakins. Upk1b(RFP/RFP) renal urothelium became stratified with altered cellular composition. Upk1b(RFP/RFP) mice developed age-dependent progressive hydronephrosis. Interestingly, 16% of Upk1b(RFP/RFP) mice possessed unilateral duplex kidneys. Our study expands the role of uroplakins, mechanistically links plaque formation to urinary tract development and function, and provides a tantalizing connection between congenital anomalies of the kidney and urinary tract along with functional deficits observed in a variety of urinary tract diseases. Thus, kidney and bladder urothelium are regionally distinct and remain highly plastic, capable of expansion through tissue-specific progenitor populations. Furthermore, Upk1b plays a previously unknown role in early kidney development representing a novel genetic target for congenital anomalies of the kidney and urinary tract.

Indexed as

Cell DifferentiationAnimalsCell ProliferationGene Expression Regulation, DevelopmentalGenotypeHomeostasisHydronephrosisKidneyMice, KnockoutPhenotypeSignal TransductionTetraspaninsUrinary BladderUrogenital AbnormalitiesUroplakin IbUrotheliumTetraspaninsUpk1b protein, mouseUroplakin IbbladderCAKUTdevelopmentkidneyuroplakinsurothelium

Identifiers

PMID26880456
PMCPMC4757817
OpenAlexW2265469630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.